查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2040576

醫療領域大規模語言模型（LLM）市場規模、佔有率和趨勢分析報告：按組件、應用、部署模式、最終用途、地區和細分市場預測（2026-2033 年）

Large Language Models In Healthcare Market Size, Share & Trends Analysis Report By Component, By Application, By Deployment Mode, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

醫療領域大規模語言模型市場概述

2025 年，全球醫療領域大規模語言模型 (LLM) 市場規模估計為 13 億美元，預計到 2033 年將達到 125 億美元。

預計從 2026 年到 2033 年，全球大規模語言模型 (LLM) 市場將以 32.3% 的複合年成長率成長。非結構化醫療數據的增加、人工智慧在醫療 IT 生態系統中的日益普及，以及藥物發現和生命科學領域應用案例的不斷增加，正在推動全球醫療領域大規模語言模型 (LLM) 市場的成長。

以下各節概述了醫療保健市場中大規模語言模型 (LLM) 成長的關鍵促進因素，重點關注非結構化醫療數據的增加、醫療保健 IT 生態系統中人工智慧的日益普及以及藥物發現和生命科學領域不斷擴大的應用案例。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 醫療領域大規模語言模型（LLM）市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 醫療領域大規模語言模型（LLM）的市場分析工具

第4章：醫療領域大規模語言模型（LLM）市場：按組件分類的估算與趨勢分析

  • 全球醫療保健產業大規模語言模型（LLM）市場：基於組件的波動分析
  • 全球醫療保健產業大規模語言模型（LLM）市場：基於組件的規模和趨勢分析（2021-2033年）
  • 軟體和 GPT 平台
  • 服務

第5章：醫療領域大規模語言模型（LLM）市場：基於應用的估算與趨勢分析

  • 全球醫療保健領域大規模語言模型（LLM）市場：基於應用的波動分析
  • 全球醫療保健產業大規模語言模型（LLM）市場：基於應用的規模和趨勢分析（2021-2033年）
  • 臨床文件和環境人工智慧
  • 臨床決策支持
  • 藥物發現與生命科學
  • 管理和收入周期管理
  • 病人參與和虛擬助手
  • 其他

第6章：醫療領域大規模語言模型（LLM）市場：按部署模式分類的估算與趨勢分析

  • 全球醫療保健產業大規模語言模式（LLM）市場：按部署模式分類的波動分析
  • 全球醫療領域大規模語言模型（LLM）市場規模及趨勢分析：依疾病分類，2021-2033年
  • 網路和雲端
  • 現場

第7章：醫療領域大規模語言模型（LLM）市場：依最終用途分類的估算與趨勢分析

  • 全球醫療保健產業大規模語言模型（LLM）市場：按最終用途分類的波動分析
  • 全球醫療保健產業大規模語言模型（LLM）市場：最終用戶規模和趨勢分析（2021-2033年）
  • 醫院
  • 私人診所/門診部
  • 製藥和生物技術公司
  • 付款人
  • 其他

第8章：醫療領域大規模語言模型（LLM）市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第9章 競爭情勢

  • 公司和競爭對手的分類
  • 策略規劃
  • 2025年公司市場分析
  • 公司簡介列表
    • MedGPT
    • OpenAI
    • Google DeepMind
    • Microsoft
    • Oracle
    • Certilytics
    • John Snow Labs
    • Merative
    • Anthropic
    • Meta AI
    • Hippocratic AI
    • Ambience Healthcare
    • Abridge AI, Inc.
    • Tempus AI
    • Aidoc
    • Viz.ai
    • Qure.ai
    • PathAI
    • Insilico Medicine
    • Owkin
    • Benevolent AI
Product Code: GVR-4-68040-897-1

Large Language Models In Healthcare Market Summary

The global large language models in healthcare market size was estimated at USD 1.3 billion in 2025 and is projected to reach USD 12.5 billion in 2033, growing at a CAGR of 32.3% from 2026 to 2033. Rising volume of unstructured healthcare data, increasing adoption of AI in healthcare IT ecosystems, expansion of use cases in drug discovery and life sciences are factors driving the growth of the global large language models (LLM) in the healthcare market.

The section below outlines the key factors driving the growth of large language models (LLM) in healthcare market, highlighting the Rising volume of unstructured healthcare data, increasing adoption of AI in healthcare IT ecosystems, and expansion of use cases in drug discovery and life sciences.

Global Large Language Models In Healthcare Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global large language models (LLM) in healthcare market report based on component, application, deployment mode, end-use, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software and GPT Platform
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical Documentation & Ambient AI
  • Clinical Decision Support
  • Drug Discovery & Life Sciences
  • Patient Engagement & Virtual Assistants
  • Administrative & Revenue Cycle Mgmt
  • Others
  • Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Web & Cloud-based
  • On-premise
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Physician Practices & Ambulatory Clinics
  • Pharmaceutical & Biotech Companies
  • Payer
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Component Segment
    • 1.2.2. Application Segment
    • 1.2.3. Deployment Mode Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Large Language Models (LLM) in Healthcare Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Large Language Models (LLM) in Healthcare Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape

Chapter 4. Large Language Models (LLM) in Healthcare Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Large Language Models (LLM) in Healthcare Market Component Movement Analysis
  • 4.3. Global Large Language Models (LLM) in Healthcare Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 4.4. Software and GPT Platform
    • 4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Large Language Models (LLM) in Healthcare Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Large Language Models (LLM) in Healthcare Market Application Movement Analysis
  • 5.3. Global Large Language Models (LLM) in Healthcare Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Clinical Documentation & Ambient AI
    • 5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Clinical Decision Support
    • 5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Drug Discovery & Life Sciences
    • 5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Administrative & Revenue Cycle Management
    • 5.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8. Patient Engagement & Virtual Assistants
    • 5.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Large Language Models (LLM) in Healthcare Market: Deployment Mode Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Large Language Models (LLM) in Healthcare Market: Deployment Mode Movement Analysis
  • 6.3. Global Large Language Models (LLM) in Healthcare Market Size & Trend Analysis, by Medical Condition, 2021 to 2033 (USD Million)
  • 6.4. Web & Cloud-based
    • 6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. On-Premise
    • 6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Large Language Models (LLM) in Healthcare Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Large Language Models (LLM) in Healthcare Market: End Use Movement Analysis
  • 7.3. Global Large Language Models (LLM) in Healthcare Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Physician Practices & Ambulatory Clinics
    • 7.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Pharmaceutical & Biotechnology Companies
    • 7.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Payers
    • 7.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Others
    • 7.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Large Language Models (LLM) in Healthcare Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.6. Norway
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2025
  • 9.4. Company Profiles/Listing
    • 9.4.1. MedGPT
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. OpenAI
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Google DeepMind
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Microsoft
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Oracle
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Certilytics
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. John Snow Labs
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Merative
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Anthropic
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Meta AI
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Hippocratic AI
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Ambience Healthcare
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. Abridge AI, Inc.
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Product benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. Tempus AI
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Product benchmarking
      • 9.4.14.4. Strategic initiatives
    • 9.4.15. Aidoc
      • 9.4.15.1. Company overview
      • 9.4.15.2. Financial performance
      • 9.4.15.3. Product benchmarking
      • 9.4.15.4. Strategic initiatives
    • 9.4.16. Viz.ai
      • 9.4.16.1. Company overview
      • 9.4.16.2. Financial performance
      • 9.4.16.3. Product benchmarking
      • 9.4.16.4. Strategic initiatives
    • 9.4.17. Qure.ai
      • 9.4.17.1. Company overview
      • 9.4.17.2. Financial performance
      • 9.4.17.3. Product benchmarking
      • 9.4.17.4. Strategic initiatives
    • 9.4.18. PathAI
      • 9.4.18.1. Company overview
      • 9.4.18.2. Financial performance
      • 9.4.18.3. Product benchmarking
      • 9.4.18.4. Strategic initiatives
    • 9.4.19. Insilico Medicine
      • 9.4.19.1. Company overview
      • 9.4.19.2. Financial performance
      • 9.4.19.3. Product benchmarking
      • 9.4.19.4. Strategic initiatives
    • 9.4.20. Owkin
      • 9.4.20.1. Company overview
      • 9.4.20.2. Financial performance
      • 9.4.20.3. Product benchmarking
      • 9.4.20.4. Strategic initiatives
    • 9.4.21. Benevolent AI
      • 9.4.21.1. Company overview
      • 9.4.21.2. Financial performance
      • 9.4.21.3. Product benchmarking
      • 9.4.21.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America large language models (LLM) in healthcare market, by region, 2021 - 2033 (USD Million)
  • Table 4 North America large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 5 North America large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 6 North America large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 7 North America large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 8 U.S. large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 9 U.S. large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 10 U.S. large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 11 U.S. large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Canada large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 13 Canada large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 14 Canada large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 15 Canada large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 17 Mexico large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 19 Mexico large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Europe large language models (LLM) in healthcare market, by region, 2021 - 2033 (USD Million)
  • Table 21 Europe large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 22 Europe large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 23 Europe large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 24 Europe large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 25 Germany large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 26 Germany large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 27 Germany large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 28 Germany large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 30 France large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 31 France large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 32 France large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 33 UK large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 34 UK large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 35 UK large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 36 UK large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 37 Italy large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 38 Italy large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 39 Italy large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 40 Italy large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Spain large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 42 Spain large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 43 Spain large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 44 Spain large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Denmark large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 46 Denmark large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 47 Denmark large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 48 Denmark large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Sweden large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 50 Sweden large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 51 Sweden large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 52 Sweden large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 53 Norway large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 54 Norway large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 55 Norway large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 56 Norway large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific large language models (LLM) in healthcare market, by region, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 62 China large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 63 China large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 64 China large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 65 China large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Japan large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 67 Japan large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 68 Japan large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 69 Japan large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 70 India large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 71 India large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 72 India large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 73 India large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 74 South Korea large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 75 South Korea large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 76 South Korea large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 77 South Korea large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 78 Australia large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 79 Australia large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 80 Australia large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 81 Australia large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Thailand large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 83 Thailand large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 84 Thailand large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 85 Thailand large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Latin America large language models (LLM) in healthcare market, by region, 2021 - 2033 (USD Million)
  • Table 87 Latin America large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 88 Latin America large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 89 Latin America large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 90 Latin America large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 91 Brazil large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 92 Brazil large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 93 Brazil large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 94 Brazil large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 95 Argentina large language models (LLM) in healthcare market, by region, 2021 - 2033 (USD Million)
  • Table 96 Argentina large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 97 Argentina large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 98 Argentina large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 99 Argentina large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 100 MEA large language models (LLM) in healthcare market, by region, 2021 - 2033 (USD Million)
  • Table 101 MEA large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 102 MEA large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 103 MEA large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 104 MEA large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 105 South Africa large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 106 South Africa large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 107 South Africa large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 108 South Africa large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 110 Saudi Arabia large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 111 Saudi Arabia large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 113 UAE large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 114 UAE large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 115 UAE large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 116 UAE large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 117 Kuwait large language models (LLM) in healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 118 Kuwait large language models (LLM) in healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 119 Kuwait large language models (LLM) in healthcare market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 120 Kuwait large language models (LLM) in healthcare market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Large language models (LLM) in healthcare market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Commodity flow analysis
  • Fig. 5 Parent market analysis
  • Fig. 6 Large language models (LLM) in healthcare market snapshot
  • Fig. 7 Large language models (LLM) in healthcare market segment snapshot (part 1)
  • Fig. 8 Large language models (LLM) in healthcare market segment snapshot (part 2)
  • Fig. 9 Large language models (LLM) in healthcare market competitive landscape snapshot
  • Fig. 10 Market research process
  • Fig. 11 Parent market outlook (USD Billion) (2025)
  • Fig. 12 Large language models (LLM) in healthcare market dynamics
  • Fig. 13 Large language models (LLM) in healthcare market: Porter's five forces analysis
  • Fig. 14 Large language models (LLM) in healthcare market: PESTLE analysis
  • Fig. 15 Large language models (LLM) in healthcare market, component outlook key takeaways (USD million)
  • Fig. 16 Large language models (LLM) in healthcare market: component movement analysis, 2025 & 2033 (USD Million)
  • Fig. 17 Software and GPT platform market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Large language models (LLM) in healthcare market, application outlook key takeaways (USD Million)
  • Fig. 20 Large language models (LLM) in healthcare market: Application movement analysis, 2025 & 2033 (USD Million)
  • Fig. 21 Clinical decision support market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Clinical documentation & ambient AI market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Drug discovery & life sciences market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Patient engagement & virtual assistants market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Administrative & revenue cycle management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Large language models (LLM) in healthcare market, deployment mode outlook key takeaways (USD Million)
  • Fig. 28 Large language models (LLM) in healthcare market: Deployment mode movement analysis, 2025 & 2033 (USD Million)
  • Fig. 29 Web & cloud-based market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 On-premise market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Large language models (LLM) in healthcare market, end use outlook key takeaways (USD Million)
  • Fig. 32 Large language models (LLM) in healthcare market: End use analysis, 2025 & 2033 (USD Million)
  • Fig. 33 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Physician practices & ambulatory clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Payers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Large Language Models (LLM) In Healthcare Market: Regional outlook
  • Fig. 40 North America large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 U.S. large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Canada large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Mexico large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 47 Europe large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 UK large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Germany large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 France large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Italy large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Spain large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Sweden large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Denmark large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Norway large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 64 Asia Pacific large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Japan large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 China large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 India large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Australia large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Thailand large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 South Korea large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 77 Latin America large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Brazil large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Argentina large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 82 MEA large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 South Africa large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Saudi Arabia large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 UAE large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Kuwait large language models (LLM) in healthcare market, 2021 - 2033 (USD Million)
  • Fig. 91 Company categorization
  • Fig. 92 Company market position analysis, 2025
  • Fig. 93 Strategic Framework